login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 




Featured Highlights
21 - 40 of 142   Items
NHS England makes selective internal radiation therapy (SIRT) available via new commissioning procedure

NHS England makes selective internal radiation therapy (SIRT) available via new commissioning procedure

Wednesday, 02 Oct 2013
The NHS revision of Clinical Policy Commissioning Statement on SIRT will allow patients in England with metastatic colorectal cancer and intrahepatic cholangiocarcinoma who may benefit from the therapy to get treatment in specialist NHS centres. NHS England makes selective internal radiation therapy (SIRT) available via new commissioning procedure

AngioDynamics highlighted new offerings at CIRSE 2013

Friday, 20 Sep 2013
Angiovac cannula and cardiopulmonary bypass circuit, Bioflo peripherally inserted central catheters, Nanoknife system, Nevertouch direct fibre and Acculis microwave system illustrate strength of company’s portfolio. AngioDynamics highlighted new offerings at CIRSE 2013
Benefits of thermal ablation in the lung in conjunction with other therapies “cannot be overstated”

Benefits of thermal ablation in the lung in conjunction with other therapies “cannot be overstated”

Friday, 23 Aug 2013
Thomas Vogl, Institute of Diagnostic and Interventional Radiology, Goethe University, Frankfurt, spoke at ECIO (19–22 June, Budapest Hungary) about novel lung ablative techniques and the evidence for combination ablative therapies. Benefits of thermal ablation in the lung in conjunction with other therapies “cannot be overstated”
ThermoDox HEAT study results to be presented at ILCA 2013

ThermoDox HEAT study results to be presented at ILCA 2013

Thursday, 22 Aug 2013
The presentation will include the most recent overall survival data. Recent HEAT study post-hoc analysis, strongly suggest positive progression-free survival and overall survival in ThermoDox treated patients when heating cycles from the radiofrequency ablation procedure were optimised. ThermoDox HEAT study results to be presented at ILCA 2013
Tumour measurements predict survival in advanced non-small cell lung cancer

Tumour measurements predict survival in advanced non-small cell lung cancer

Wednesday, 21 Aug 2013
For the two-thirds of lung cancer patients with locally advanced or metastatic disease, tumour size is not used currently to predict overall survival times. A new study, however, led by UT Southwestern Medical Center researchers has shown that even in advanced stages, total tumour size can have a major impact on survival. Tumour measurements predict survival in advanced non-small cell lung cancer
Older liver cancer patients respond to radioembolization as well as younger patients, study says

Older liver cancer patients respond to radioembolization as well as younger patients, study says

Tuesday, 13 Aug 2013
Results of an analysis by members of the multicentre European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY), published online in late May in the Journal of Hepatology, may have important implications for older patients with inoperable primary liver cancer. Older liver cancer patients respond to radioembolization as well as younger patients, study says

Noted interventional radiologists join Surefire Medical’s scientific advisory board

Tuesday, 13 Aug 2013
Surefire Medical has announced that Gordon McLennan, Cleveland Clinic and Fred Moeslein, University of Maryland Medical Center, have joined the company’s scientific advisory board. Noted interventional radiologists join Surefire Medical’s scientific advisory board
NICE recommends selective internal radiation therapy for treatment of primary and secondary liver cancer

NICE recommends selective internal radiation therapy for treatment of primary and secondary liver cancer

Wednesday, 31 Jul 2013
BTG announced on 30 July that the National Institute for Health and Clinical Excellence (NICE) has issued guidance recommending the use of selective internal radiation therapy (SIRT), which includes TheraSphere, for patients with liver cancer across the NHS. NICE recommends selective internal radiation therapy for treatment of primary and secondary liver cancer
Surefire infusion system safe and effective for delivery of Y90

Surefire infusion system safe and effective for delivery of Y90

Wednesday, 10 Jul 2013
Case reports published in the Journal of Cardiovascular and Interventional Radiology show that the Surefire Infusion System can safely and effectively Y90 in order to treat inoperable liver cancer. Surefire infusion system safe and effective for delivery of Y90
Sirtex to distribute Surefire Medical’s infusion system in Australia and Asia-Pacific markets

Sirtex to distribute Surefire Medical’s infusion system in Australia and Asia-Pacific markets

Wednesday, 26 Jun 2013
Sirtex Medical and US-based Surefire Medical has announced a sales and marketing partnership to distribute Surefire’s range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets. Sirtex to distribute Surefire Medical’s infusion system in Australia and Asia-Pacific markets
SARAH study enroling patients throughout France for the treatment of primary liver cancer

SARAH study enroling patients throughout France for the treatment of primary liver cancer

Tuesday, 25 Jun 2013
Launched by the Assistance Publique Hôpitaux de Paris, France, in December 2011, SARAH (Sorafenib versus radioembolization in advanced hepatocellular carcinoma), a French national collaborative randomised controlled trial of radioembolization with yttrium-90 resin microspheres vs. sorafenib in advanced hepatocellular carcinoma has announced it is seeking to enrol 400 patients. SARAH study enroling patients throughout France for the treatment of primary liver cancer
Radiosurgery treatments for lung cancer using Varian Medical Systems Technologies presented at ESTRO

Radiosurgery treatments for lung cancer using Varian Medical Systems Technologies presented at ESTRO

Tuesday, 07 May 2013
Cancer experts have reported future trends and progress in radiotherapy treatments for lung cancer using motion management and tumour-tracking technologies from Varian Medical Systems at the annual ESTRO Forum (19–23 April 2013, Geneva, Switzerland). Radiosurgery treatments for lung cancer using Varian Medical Systems Technologies presented at ESTRO
Cost effective prostate cancer treatment underused in the UK

Cost effective prostate cancer treatment underused in the UK

Friday, 03 May 2013
Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery according to study findings conducted by Panaxea, The University of Twente, The Netherlands. Cost effective prostate cancer treatment underused in the UK
Elekta receives FDA 510(k) clearance for Versa HD Radiation Therapy System for cancer treatment

Elekta receives FDA 510(k) clearance for Versa HD Radiation Therapy System for cancer treatment

Friday, 12 Apr 2013
Elekta recently received 510(k) clearance from the US Food and Drug Administration (FDA) which allows the company to begin shipping and installation of all components of the Versa HD system within the USA. Elekta receives FDA 510(k) clearance for Versa HD Radiation Therapy System for cancer treatment

Medwaves announces the first successful use of hot and cold thyroid nodules with AveCure Microwave Ablation System and radioiodine

Friday, 12 Apr 2013
Hudayi Korkusuz, Hospital of Johann Wolfgang Goethe University, Frankfurt, Germany, has conducted the first combination treatment of microwave ablation and radiotherapy, according to a press release. Medwaves announces the first successful use of hot and cold thyroid nodules with AveCure Microwave Ablation System and radioiodine

Nordion to host European-based educational and scientific meetings for liver cancer specialists

Thursday, 11 Apr 2013
On 11–12 April, Nordion will host its 3rd European TheraSphere User Group Meeting in Vienna, Austria, and on 18 April, Nordion will offer a Satellite Symposium at the 3rd Interdisciplinary Treatment of Liver Tumors (ITLT) Meeting in Essen, Germany, according to a company release. Nordion to host European-based educational and scientific meetings for liver cancer specialists

BSD Medical announces distribution agreement with Terumo Europe for the MicroThermX Microwave Ablation System

Thursday, 11 Apr 2013
BSD Medical announced today that the company has signed an exclusive, long-term, multi-million dollar distribution agreement with Terumo Europe, a wholly owned subsidiary of Terumo Corporation, for the MicroThermX Microwave Ablation System. BSD Medical announces distribution agreement with Terumo Europe for the MicroThermX Microwave Ablation System
Nordion to host interactive TheraSphere educational session at the Society of Interventional Radiology Annual Scientific Meeting

Nordion to host interactive TheraSphere educational session at the Society of Interventional Radiology Annual Scientific Meeting

Thursday, 11 Apr 2013
Nordion a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host an educational session called “TheraSphere test flight interactive: How to treat or should I treat?” at the Society for Interventional Radiology’s (SIR) Annual Scientific Meeting (13–18 April, New Orleans, USA). Nordion to host interactive TheraSphere educational session at the Society of Interventional Radiology Annual Scientific Meeting
First centre in Hong Kong treats patients with CyberKnife and TomoTherapy systems

First centre in Hong Kong treats patients with CyberKnife and TomoTherapy systems

Friday, 22 Mar 2013
Accuray has reported that the Hong Kong Adventist Oncology Center has treated patients with the CyberKnife and TomoTherapy systems. First centre in Hong Kong treats patients with CyberKnife and TomoTherapy systems
ONCOassist oncology app has received the CE mark

ONCOassist oncology app has received the CE mark

Thursday, 21 Mar 2013
Portable Medical, according to the company website, has received the CE mark for its oncology decision-making smartphone app—ONCOassist. The app was developed in conjunction with doctors and is classed as a medical device in accordance with EU regulations. ONCOassist oncology app has received the CE mark
Found: 142   Displaying: 21-40
Results: 1 2 3 4 5 Next Go to:

Related Section


Clinical Trials
Interventional Oncology News
Interventional Oncology Supplement
Key Opinion Leaders discuss the role of Biocompatible's DC Bead at CIRSE and ILCA
IR Views
Literature
Oncology Useful Links

Related Feeds


Most popular


OVER analysis: Endoleak does not predict reduced long-term survival but negatively impacts sac regression
Wednesday, 18 Jun 2014
An analysis of the OVER trial presented at the Society for Vascular Surgery Vascular Annual Meeting (SVS, 5–7 June, Boston, USA) shows that the development of endoleaks were common in patients ... OVER analysis: Endoleak does not predict reduced long-term survival but negatively impacts sac regression

Medtronic to acquire Covidien for US$42.9 billion in cash and stock
Monday, 16 Jun 2014
The acquistion creates a medical technology and services company with a comprehensive product portfolio and broad global reach. Medtronic to acquire Covidien for US$42.9 billion in cash and stock

FDA advisory panel unanimously recommends approval for Lutonix DCB
Friday, 13 Jun 2014
Lutonix DCB is one step closer to becoming the first US FDA-approved drug-coated balloon for the treatment of patients with femoropopliteal occlusive disease. FDA advisory panel unanimously recommends approval for Lutonix DCB

Features


The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha
Tuesday, 08 Jul 2014
The 11th Scientific Meeting of the Chinese Society of Interventional Radiology (2014 CSIR) was held from 11–15 June 2014 in Changsha, Hunan Province, China. The Chinese Society of Interventional R... The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha

Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy
Tuesday, 08 Jul 2014
Unintended non-target delivery of embolic agents into any of the various hepaticoentric arteries that course from an intrahepatic artery to implant into an extra hepatic organ such as the stomach or ... Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Profiles


Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

James B Spies
Friday, 16 May 2014
The evolution of embolization over the past decade has been remarkable and it has fundamentally ... James B Spies

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions